Any new or unusual symptom after dosing. Because this compound has little or no human safety data, there is no established list of 'expected' effects to reassure you against — treat anything abnormal as a signal.
Stop at the first clearly abnormal reaction and reassess. Keep the vial and lot number in case you need to describe what you actually took.
Any severe or fast-worsening symptom — difficulty breathing, chest pain, fainting, severe pain — is a 911 call regardless of the compound.
Allergic reaction: hives, swelling of the lips, tongue or throat, wheezing or dizziness can escalate to anaphylaxis within minutes — call 911 immediately. Site infection: spreading redness, heat, swelling, pus or fever is not wait-and-see; an abscess or cellulitis can need drainage or IV antibiotics. Unverified product: grey-market vials are frequently mislabelled or contaminated, so a reaction may be to endotoxin or the wrong contents, not the named compound.
A naturally occurring thymic peptide that promotes T-cell maturation and dendritic cell function, acting substantially through Toll-like receptor signalling. It shifts immune responses toward Th1 and augments antigen presentation. Unlike most peptides in this library, its mechanism is comparatively well characterised.
Studied in chronic hepatitis B and C, as a vaccine adjuvant, in sepsis, and in cancer immunotherapy contexts. Trial results are mixed but the human evidence base is real and substantially larger than for the grey-market peptides.
Not FDA-approved. Approved and marketed in roughly 30 other countries (as Zadaxin) for hepatitis B and C and as a vaccine adjuvant. Was subject to FDA 503A bulk substance review.
Generally well tolerated in trials. Immunostimulation carries theoretical concerns in autoimmune disease and transplant recipients.
Zadaxin (approved abroad): 1.6 mg SC twice weekly for hepatitis B. Trial doses vary by indication. Not FDA-approved.
Reported from clinical trials or FDA labelling as a matter of record. It is not a recommendation, and for unapproved compounds no dose has been shown safe or effective in humans.
Above is what was administered in trials or on FDA labels, reported as fact. We do not convert it into a personal protocol, calculate a dose for your body weight, or tell you what to inject or how to reconstitute it — that decision belongs with a licensed physician. See our editorial policy.
Regulatory status changes. This page reflects our reading of public sources as of July 2026 and should be independently verified before it is relied upon.